REFERENCES
- Frank MO, Sullivan GW, Carper HT, Mandell GL. In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes. Antimicrob Agents Chemother 1992; 36: 2584–2588.
- Butts JD. Intracellular concentrations of antibacterial agents and related clinical implications. Clin Pharmacokinet 1994; 27: 63–84.
- Tulkens PM. Intracellular pharmacokinetics and local-ization of antibiotics as predictors of their efficacy against intraphagocytic infections. Scand J Infect Dis 1991; 74 suppl: 209-217.
- Anderson R, Joone G, van Rensburg CEJ. An in- vitro evaluation of the cellular uptake and intraphagocytic bioactiv-ity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent. J Antimicrob Chemother 1988; 22: 923–933.
- Carher MB, Zenebergh A, Tulkens PM. Cellular uptake and subcellular distribution of roxithromycin and ery-thromycin in phagocytic cells. J Antimicrob Chemother 1987; 20 (suppl1B): 47-56.
- Fietta A, Boeri P, Colombo ML, Merlini C, Gialdroni Grassi G. Uptake of flurithromycin by human polymor-phonuclear phagocytes: partial characterization of the entry mechanism. Chemotherapy 1992; 38: 433–440.
- Ishiguro M, Koga H, Kohno S, Hayashi T, Yamaguchi K, Hirota M. Penetration of macrolides into human polymor-phonuclear leukocytes. J Antimicrob Chemother 1989; 24: 719–729.
- Johnson JD, Hand WL, Hand JB, Francis N, King-Thompson N, Corwin RV. Antibiotic uptake by alveolar macrophages. J Lab Chin Med 1980; 95: 429–439.
- Kohno Y, Yoshida H, Suwa T, Suga T. Uptake of clar-ithromycin by rat lung cells. J Antimicrob Chemother 1990; 26: 503–513.
- Prokesch RC, Hand WL. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1982; 21: 373–380.
- Hand WL, King-Thompson NL. The entry of antibi-otics into human monocytes. J Antimicrob Chemother 1989; 23: 681–689.
- Hand WL, King-Thompson N, Holman JW. Entry of roxithromycin (RU965), imipenem, cefotaxime, trimethoprim and metronidazole into human polymorphonuclear leuko-cytes. Antimicrob Agents Chemother 1987; 31: 1553-1557.
- Baughman PP, De Sante KA, Lanier TL, Conforti PM, Sides GD. The penetration of dirithromycin into bron-choalveolar lavage fluid and alveolar macrophages. J Antimicrob Chemother 1994; 33: 1045–1050.
- Hand WL, Hand DL. Interactions of dirithromycin with human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1993; 37: 2557–2562.
- Mtairag EM, Abdelghaffar H, Labro MT. Investigation of dirithromycin and erythromycylamine uptake by human neutrophils in vitro. J Antimicrob Chemother 1994; 33: 523–536.
- Blais J, Beauchamp D, Chamberland S. Azithromycin uptake and intracellular accumulation by Toxoplasmagondii-infected macrophages. J Antimicrob Chemother 1994; 43: 371–382.
- Bonnet M, Van der Auwera P. In vitro and in vivo intraleukocytic accumulation of azithromycin (CF 62,993) and its influence on ex vivo leukocyte chemiluminescence. Antimicrob Agents Chemother 1992; 36: 1302-1309.
- Freeman CD, Nightingale CH, Nicolau DP, Belliveau PP, Banevicius MA, Quintiliani R. Intracellular and extracel-lular penetration of azithromycin into inflammatory and non-inflammatory blister fluid. Antimicrob Agents Chemother 1994; 38: 2449–2451.
- Gladue RP, Bright GM, Isaacson RE, Newborg MF. In vitro and in vivo uptake of azithromycin (CF 62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 1989; 33: 277–382.
- Gladue RP, Snider ME. Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrob Agents Chemother 1990; 34: 1056–1060.
- Laufen H, Wildfeuer A, Lach P. Mechanism of azithromycin uptake in human polymorphonuclear leuco-cytes. Arzneim Forsch/ Drug Res 1990; 40: 686–689.
- McDonald PJ, Pruul H. Phagocyte uptake and trans-port of azithromycin. Eur J Chin Microbiol Infect Dis 1991; 10: 823–833.
- Meyer AP, Bril-Bazuin C, Mattie H, Van den Broek PJ. Uptake of azithromycin by human monocytes and enhanced intracellular activity against Staphylococcus aureus. Antimicrob Agents Chemother 1993; 37: 2318–2322.
- Panteix G, Guillaumond B, Harf R et al. In vitro con-centration of azithromycin in human phagocytic cells. J Antimicrob Chemother 1993; 31 (suppl E): 1-4.
- Reijngoud DJ, Tager JM. The permeability properties of lysosomal membranes. Biochem Biophys Acta 1977; 472: 410–449.
- Wildfeuer A, Laufen H, Zimmermann T. Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions. Antimicrob Agents Chemother 1996; 40: 75–79.
- Raghoebar M, Lindeyer E, Van den Berg WB, Van Ginneken CAM. On the mechanisms of association of the macrolide antibiotic erythromycin with isolated human poly-morphonuclear leucocytes. Biochem Pharmacol 1988; 38: 3221–3227.
- Laufen H, Wildfeuer A. Kinetics of the uptake of antimicrobial agents by human polymorphonuclear leuco-cytes. Arzneim-Forsch/Drug Res 1989; 39: 233–235.
- Senior RM, Campbell EJ, Villiger B. Obtaining and cul-turing human and animal alveolar macrophages. In: Adams DO, Edelson PJ, Karen H, eds. Methods for studying mononuclear phagocytes. New York-London: Academic Press, 1981: 69–83.
- Girard AE, Girard D, English A et al. Pharmakokinetic and in vivo studies with azithromycin (CP62,993), a new macrolide with an extended half-life and excellent tissue dis-tribution. Antimicrob Agents Chemother 1987; 31: 1948–1954.
- Kempner MS, Styr B. Clindamycin uptake by human neutrophils. J Infect Dis 1981; 144: 472–475.
- Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER. Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 1982; 125: 332–337.
- Nibbering PH, Zomerdisk TPL, Corsel-Van Tilburg AJ, Van Furth R. Mean cell volume of human blood leuko- cytes and resident and activated murine macrophages. J Immunol Meth 1990; 129: 143–145.
- Segel IH. Effects of pH and temperature. In: Wiley Interscience publication. Enzyme kinetics—behavior and analysis of rapid equilibrium and steady state enzyme systems. New York-Chichester: Wiley & Sons J, Inc, 1993: 884-942.
- Dunn CJ, Barradell LB. Azithromycin - a review of its pharmacological properties and use as 3-day therapy in respi-ratory tract infections. Drugs 1996; 51: 483–505.
- Pascual A, Conejo MC, Garcia I, Perea EJ. Factors affecting the intracellular accumulation and activity of azithromycin. J Antimicrob Chemother 1995; 35: 85–93.
- Mtairag EM, Abdelghaffar H, Douhet C, Labro MT. Role of extracellular calcium in in-vitro uptake and intraphagocytic location of macrolides. Antimicrob Agents Chemother 1995; 39: 1676–1682.
- Barradell LB, Plasker GL, Metavish D. Clarythromycin - A review of its pharmacological properties and therapeutic use in Mycobacterium avium-intracellulare complex infection in patients with acquired immune deficiency syndrome. Drugs 1993; 46: 289–312.